MediBridge Consumer Solutions, Inc. • BeneBridge360™ member advocacy & cost containment platform
¹ Refer to definition on Page 7.
Term | Detail |
---|---|
Instrument | SAFE — Post-Money (YC standard form) |
Purchase Amount | $250,000 |
Valuation Cap | $6,000,000 |
Discount | 20% (applies if next round valuation is below the cap) |
Pro Rata Rights | Yes — maintain ownership in future rounds (customary exceptions) |
Conversion Trigger | Next equity financing ≥ $1,000,000 |
Liquidity Event | Greater of 2× cash return or as-converted proceeds |
Maturity / Interest | No maturity; no interest — SAFE is not debt |
Governing Law | Delaware |
Founder-friendly, market-standard structure. Clear upside for early investors via cap + discount.
BeneBridge360™ lowers employee out-of-pocket costs and eliminates billing confusion by intercepting claims, negotiating with providers, and pre-paying balances when needed — then giving members simple payment options.
Deployed alongside 5Star’s Hospital Indemnity / Gap offerings, initially reaching 30,000+ members. MediBridge provides the member advocacy & savings engine behind the scenes.
Total: $205,000 • Remaining funds cover working capital for rollout.
Spend is tightly focused on technology enablement, regulatory readiness, and operational go-live to support carrier & broker channels.
Primary driver: IT integration for claim ingestion, bill review, and member engagement.
2025 Pre-Funding Cash | Funding Request | Post-Funding Cash |
---|---|---|
$0 | $250,000 | $143,050 |
Your model projects positive cash through rollout with this raise.
Year | Revenue | Net Profit | End-of-Year Cash |
---|---|---|---|
2025 | $171,961 | ($106,950) | $143,050 |
2026 | $1,310,930 | $342,065 | $485,114 |
2027 | $2,423,611 | $760,361 | $1,245,475 |
2028 | $2,878,881 | $882,596 | $2,128,071 |
Projections pulled from your “Medibridge Financial Model_July 2025_v3_CONSERVATIVE.xlsx”.
Note: Conservative model assumes only customer is 5Star and does not reflect other likely customers.
Post-Money form (adapted). Recommend counsel review to confirm Delaware boilerplate and capitalization definition alignment.
Company: MediBridge Consumer Solutions, Inc. (Delaware)
Investor: [Investor Name]
Purchase Amount: $250,000
Valuation Cap: $6,000,000
Discount: 20%
Date: [●]
If the Company closes a bona fide equity financing of ≥ $1,000,000 (the “Equity Financing”) prior to termination of this SAFE, this SAFE automatically converts into the greater number of shares of the standard preferred stock sold in that financing determined by (a) the Valuation Cap Price or (b) the Discount Price. “Valuation Cap Price” means a price per share based on a $6,000,000 post-money company valuation (calculated using Company Capitalization immediately prior to the financing). “Discount Price” means the price per share paid by the new money investors multiplied by 80%.
If a liquidity event (change of control or IPO) occurs before conversion, the Investor will receive the greater of: (i) a cash payment equal to 2× the Purchase Amount, or (ii) the amount payable on the number of shares of common stock issuable upon conversion at the Valuation Cap Price immediately prior to the event.
Prior to conversion, upon a voluntary or involuntary dissolution or winding up, the Investor is entitled to receive the Purchase Amount, ranking pari passu with other SAFEs and preferred stockholders, before any distribution to common stockholders.
Subject to customary exceptions, Investor may purchase its pro rata share of securities offered in future equity financings to maintain its ownership percentage on an as-converted basis.
“Company Capitalization” means all shares of capital stock issued and outstanding, all issued and outstanding options and promised but unissued options, and all outstanding convertible securities, in each case immediately prior to the Equity Financing.
This SAFE terminates upon the earliest of: (a) conversion into equity in an Equity Financing; (b) payment or settlement in connection with a Liquidity Event; or (c) payment in connection with a Dissolution.
Company: MediBridge Consumer Solutions, Inc.
By: ____________________________ Name: Phil Dawes Title: President
Investor: ____________________________ Name / Title: __________________
Pre-funding cash (2025): $0 • Funding (2025 draw): $250,000 • Post-funding cash (2025): $143,050
Year | Revenue | Net Profit | End-of-Year Cash |
---|---|---|---|
2025 | $171,961 | ($106,950) | $143,050 |
2026 | $1,310,930 | $342,065 | $485,114 |
2027 | $2,423,611 | $760,361 | $1,245,475 |
2028 | $2,878,881 | $882,596 | $2,128,071 |
Projections pulled from “Medibridge Financial Model_July 2025_v3_CONSERVATIVE.xlsx”.
Note: Conservative model assumes only customer is 5Star and does not reflect other likely customers.